Solubilised protein vaccines
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Oct 2, 2003
app pub date -
Apr 21, 2003
filing date -
Jun 21, 2000
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention relates to pharmaceutical vaccine compositions for treating or alleviating self-protein-mediated inflammatory pathologies, such as rheumatoid arthritis, Crohn's disease, enflammatory bowel disease, which vaccine compositions comprise a modified immunogenic self-protein and a surfactant capable of acting as a solubiliser. Compositions of modified human TNFalpha and cetylpyrimydium are provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully